Related Experiment Video
Updated: Jul 11, 2026

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
Drug-induced cholestasis. Clinical contribution
F D'Amore1, A Agostino, A Santoro
1II Divisione di Medicina, Ospedale Sandro Pertini, Roma, Italy.
Two drug-induced hepatitis cases revealed hypersensitivity mechanisms. Naproxen caused cholestatic jaundice, while alpha-methyldopa led to liver cell necrosis, highlighting diagnostic challenges in drug-induced liver injury.
Area of Science:
- Hepatology
- Clinical Medicine
- Pharmacology
Background:
- Drug-induced liver injury (DILI) is a significant clinical concern.
- Hypersensitivity reactions are a known, yet complex, mechanism of DILI.
- Understanding diverse DILI presentations is crucial for accurate diagnosis and management.
Purpose of the Study:
- To present two distinct cases of drug-induced hepatitis.
- To elucidate the underlying hypersensitivity pathogenesis in these cases.
- To highlight the diagnostic and clinical management challenges posed by severe DILI.
Main Methods:
- Case report analysis of two patients with drug-induced hepatitis.
- Histopathological examination of liver biopsies.
- Clinical data review including symptoms, diagnosis, and treatment.
Main Results:
- Case 1 (Naproxen): Presented with severe cholestatic jaundice and a histological pattern of ductular cholestasis without inflammation.
- Case 2 (alpha-methyldopa): Characterized by extensive liver cell necrosis and portal inflammation.
- Both cases demonstrated a hypersensitivity-mediated pathogenesis.
Conclusions:
- Drug-induced hepatitis can manifest with diverse clinical and histological features.
- Hypersensitivity is a key mechanism in certain DILI cases.
- Prompt recognition and careful follow-up are essential for managing severe drug-induced liver injury.
Related Concept Videos
Cholecystitis
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Chronic Pancreatitis II: Pathophysiology
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis I: Introduction
Chronic Pancreatitis II: Collaborative Care
Assessment:
